1.
Rehman HMY, Khattak AL, Khan TA, Tariq AM, Satti SA, Din RU. LIPID-LOWERING EFFICACY OF 20 MG SIMVASTATIN VERSUS 5 MG ROSUVASTATIN IN PATIENTS OF TYPE 2 DIABETES. PAFMJ [Internet]. 2020 Aug. 19 [cited 2024 May 14];70(4):885-89. Available from: https://pafmj.org/PAFMJ/article/view/5050